HOME Previous Columns Email Contacts Advertising

Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy.
Carcinogenesis. 1998 Sep;19(9):1679-84.
[MEDLINE record in process]
PMID: 9771941; UI: 98442884.

Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link?
Nutr Rev. 1998 Sep;56(9):275-9.
[MEDLINE record in process]
PMID: 9763878; UI: 98436369.

< Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels.
Metabolism. 1998 Aug;47(8):988-92.
PMID: 9711997; UI: 98375815.

< A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
J Clin Endocrinol Metab. 1998 Aug;83(8):2694-8.
Essential fatty acids, insulin resistance, and breast cancer risk.
Nutr Cancer. 1998;31(1):72-7. Review.
PMID: 9682252; UI: 98347174.

Insulin-sensitising agents in polycystic-ovary syndrome.
Lancet. 1998 Jan 31;351(9099):305-7. PMID: 9652605; UI: 98314713.

Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity.
Eur Rev Med Pharmacol Sci. 1997 Sep-Oct;1(5):167-71.
PMID: 9630759; UI: 98294215.

New approaches to insulin resistance in polycystic ovarian syndrome.
Curr Opin Obstet Gynecol. 1998 Jun;10(3):193-8. Review. PMID: 9619341; UI: 98283100.

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease.
Kidney Int. 1998 May;53(5):1343-7.
PMID: 9573550; UI: 98234632.

Insulin sensitizing agents and polycystic ovary syndrome.
Eur J Endocrinol. 1998 Mar;138(3):253-4. PMID: 9539295; UI: 98198701.

Current concepts of polycystic ovary syndrome.
Baillieres Clin Obstet Gynaecol. 1997 Jun;11(2):307-33. Review. PMID: 9536213; UI: 98197275.

Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease.
Metabolism. 1998 Feb;47(2):158-62.
PMID: 9472963; UI: 98132305.

Insulin resistance and promotion of aberrant crypt foci in the colons of rats on a high-fat diet.
Nutr Cancer. 1997;29(1):69-76.
PMID: 9383787; UI: 98045045.

Polycystic ovary syndrome.
Endocrinol Metab Clin North Am. 1997 Dec;26(4):893-912. Review.
PMID: 9429864; UI: 98091699.

Insulin regulation of human ovarian androgens.
Hum Reprod. 1997 Oct;12 Suppl 1:53-62. Review. PMID: 9403321; UI: 98067025.

Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.
Hum Reprod. 1997 Sep;12(9):1897-901.
PMID: 9363702; UI: 98028332.

Macronutrient supplements may reduce breast cancer risk: how, when and which?
Eur J Clin Nutr. 1997 Sep;51(9):573-7. Review.
PMID: 9306082; UI: 97451106.

Does postprandial hypersinsulinemia contribute to hyperandrogenism in patients with polycystic ovary syndrome?
Clin Exp Obstet Gynecol. 1997;24(2):88-91. PMID: 9342471; UI: 98001823.

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
J Clin Endocrinol Metab. 1997 Jul;82(7):2108-16.
PMID: 9215280; UI: 97358160.

Insulin resistance in polycystic ovary syndrome.
Curr Opin Obstet Gynecol. 1997 Jun;9(3):193-201. Review.
PMID: 9263704; UI: 97409329.
READ DL Dewey's
Previous Column
Hydrogenated Oils Are Silent Killers

HOME Previous Columns Email Contacts Advertising

©1997, 1998, 1999 Rocky Mountain Publicity
Updated October 7th, 1999
Email Contacts